Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.

被引：0
|
作者：
Nakagami, Y. [1 ]
Kano, D. [1 ]
Kusumoto, M. [1 ]
机构：
[1] Natl Canc Ctr, Chiba, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P747
引用
收藏
页码：S698 / S699
页数：2
相关论文
共 50 条
  • [21] Bone scan index as a new imaging biomarker in response assessment of prostate cancer patients with bone metastasis
    Park, Sonya
    Srinivas, Sandy
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [22] Bone scintigraphy to evaluate response to therapy with Radium-223 for castration-resistant prostate cancer patients with bone metastases: a single-center experience
    Martinez Albero, E.
    Gomez Grande, A.
    Saviatto Nardi, A.
    Galiana Moron, A.
    Vega Perez, D.
    Godigna Guilloteau, V.
    Pilkington Woll, J.
    Ruiz Solis, S.
    Sarandeses Fernandez, P.
    Tabuenca Mateo, M.
    Estenoz Alfaro, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S696
  • [23] Radium-223 dichloride - Efficacy and mode-of-action in a mouse model of prostate cancer bone metastasis
    Suominen, M. I.
    Fagerlund, K. M.
    Rissanen, J. P.
    Konkol, Y.
    Alhoniemi, E.
    Mumberg, D.
    Ziegelbauer, K.
    Kakonen, S. M.
    Halleen, J. M.
    Vessella, R. L.
    Scholz, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 25 - 26
  • [24] The effects of prednisone, abiraterone acetate and radium-223 dichloride on bone in the intratibial LNCaP prostate cancer model
    Suominen, Mari, I
    Knuuttila, Matias
    Sjoholm, Birgitta
    Alhoniemi, Esa
    Mumberg, Dominik
    Halleen, Jussi M.
    Kaekoenen, Sanna-Maria
    Scholz, Arne
    CANCER RESEARCH, 2020, 80 (16)
  • [25] Radium-223 Dichloride: A Novel Treatment Option for Castration-Resistant Prostate Cancer Patients With Symptomatic Bone Metastases
    McGann, Shane
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 469 - 476
  • [26] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
    Shirley, Matt
    McCormack, Paul L.
    DRUGS, 2014, 74 (05) : 579 - 586
  • [27] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
    Matt Shirley
    Paul L. McCormack
    Drugs, 2014, 74 : 579 - 586
  • [28] Value of bone scan index for predicting overall survival among patients treated with radium-223 for bone metastatic castration-resistant prostate cancer.
    Yoneyama, Shuko
    Miyoshi, Yasuhide
    Tsutsumi, Sohgo
    Kawahara, Takashi
    Hattori, Yusuke
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Yao, Masahiro
    Uemura, Hiroji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223
    Miyoshi, Yasuhide
    Tsutsumi, Sohgo
    Kawahara, Takashi
    Yasui, Masato
    Uemura, Koichi
    Yoneyama, Shuko
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Yao, Masahiro
    Uemura, Hiroji
    BJUI COMPASS, 2021, 2 (01): : 24 - 30
  • [30] Quantitative Assessment of Skeletal Tumor Burden in Bone Scintigraphy as a prognostic biomarker in Radium-223-dichloride Therapy
    Soeiro, P.
    Silva, R.
    Gil, P.
    Pena, H.
    Cantinho, G.
    Costa, G.
    Lima, A.
    Ferreira, I.
    Alburqueque, A.
    Gouveia, P.
    Pedroso Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S566 - S567
12345